BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 11040941)

  • 1. Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia.
    Sotlar K; Marafioti T; Griesser H; Theil J; Aepinus C; Jaussi R; Stein H; Valent P; Horny HP
    Mol Pathol; 2000 Aug; 53(4):188-93. PubMed ID: 11040941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of c-kit point mutation Asp-816 --> Val in microdissected pooled single mast cells and leukemic cells in a patient with systemic mastocytosis and concomitant chronic myelomonocytic leukemia.
    Sotlar K; Fridrich C; Mall A; Jaussi R; Bültmann B; Valent P; Horny HP
    Leuk Res; 2002 Nov; 26(11):979-84. PubMed ID: 12363464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val.
    Sperr WR; Walchshofer S; Horny HP; Födinger M; Simonitsch I; Fritsche-Polanz R; Schwarzinger I; Tschachler E; Sillaber C; Hagen W; Geissler K; Chott A; Lechner K; Valent P
    Br J Haematol; 1998 Dec; 103(3):740-9. PubMed ID: 9858225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD).
    Sotlar K; Colak S; Bache A; Berezowska S; Krokowski M; Bültmann B; Valent P; Horny HP
    J Pathol; 2010 Apr; 220(5):586-95. PubMed ID: 20112369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A variant c-KIT mutation, D816H, fundamental to the sequential development of an ovarian mixed germ cell tumor and systemic mastocytosis with chronic myelomonocytic leukemia.
    Mitchell SG; Bunting ST; Saxe D; Olson T; Keller FG
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27781377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL).
    Horny HP; Sotlar K; Stellmacher F; Valent P; Grabbe J
    J Clin Pathol; 2006 Mar; 59(3):264-8. PubMed ID: 16505276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis.
    Taylor ML; Sehgal D; Raffeld M; Obiakor H; Akin C; Mage RG; Metcalfe DD
    J Mol Diagn; 2004 Nov; 6(4):335-42. PubMed ID: 15507672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukaemia with t(8;21) associated with "occult" mastocytosis. Report of an unusual case and review of the literature.
    Bernd HW; Sotlar K; Lorenzen J; Osieka R; Fabry U; Valent P; Horny HP
    J Clin Pathol; 2004 Mar; 57(3):324-8. PubMed ID: 14990611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.
    Sotlar K; Bache A; Stellmacher F; Bültmann B; Valent P; Horny HP
    J Mol Diagn; 2008 Jan; 10(1):58-66. PubMed ID: 18165278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val.
    Jordan JH; Fritsche-Polanz R; Sperr WR; Mitterbauer G; Födinger M; Schernthaner GH; Christian Bankl H; Gebhart W; Chott A; Lechner K; Valent P
    Leuk Res; 2001 Jul; 25(7):627-34. PubMed ID: 11377687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in mastocytosis research. Summary of the Vienna Mastocytosis Meeting 1998.
    Valent P; Escribano L; Parwaresch RM; Schemmel V; Schwartz LB; Sotlar K; Sperr WR; Horny HP
    Int Arch Allergy Immunol; 1999 Sep; 120(1):1-7. PubMed ID: 10529583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
    Valent P; Sperr WR; Samorapoompichit P; Geissler K; Lechner K; Horny HP; Bennett JM
    Leuk Res; 2001 Jul; 25(7):595-602. PubMed ID: 11377685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers.
    Horny HP; Sotlar K; Stellmacher F; Krokowski M; Agis H; Schwartz LB; Valent P
    J Clin Pathol; 2006 Mar; 59(3):298-302. PubMed ID: 16505282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge.
    Horny HP; Sotlar K; Sperr WR; Valent P
    J Clin Pathol; 2004 Jun; 57(6):604-8. PubMed ID: 15166264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic myelogenous leukemia with acquired c-kit activating mutation and transient bone marrow mastocytosis.
    Cairoli R; Grillo G; Beghini A; Cornacchini G; Larizza L; Morra E
    Hematol J; 2004; 5(3):273-5. PubMed ID: 15167915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.
    Nagata H; Worobec AS; Oh CK; Chowdhury BA; Tannenbaum S; Suzuki Y; Metcalfe DD
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10560-4. PubMed ID: 7479840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816V.
    Noack F; Sotlar K; Notter M; Thiel E; Valent P; Horny HP
    Leuk Lymphoma; 2004 Nov; 45(11):2295-302. PubMed ID: 15512820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis.
    Fritsche-Polanz R; Jordan JH; Feix A; Sperr WR; Sunder-Plassmann G; Valent P; Födinger M
    Br J Haematol; 2001 May; 113(2):357-64. PubMed ID: 11380399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of bone marrow lymphocytes in systemic mastocytosis: reactive lymphocytosis or malignant lymphoma? Immunohistochemical and molecular findings on routinely processed bone marrow biopsy specimens.
    Horny HP; Lange K; Sotlar K; Valent P
    J Clin Pathol; 2003 Aug; 56(8):575-8. PubMed ID: 12890804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.